Melody Harris serves as the President of Enterprise Operations at NEOGENOMICS INC, a leading cancer genetics testing and information services company. In her role, Harris is responsible for overseeing the company's operational strategy, ensuring the delivery of high-quality, innovative solutions to healthcare providers and patients worldwide. Her leadership is instrumental in driving NEOGENOMICS' mission to improve patient outcomes through advanced genomic testing and data analytics. Prior to joining NEOGENOMICS, Harris held several senior leadership positions in the healthcare and life sciences industry. She has a proven track record of successfully managing complex operations, implementing process improvements, and fostering a culture of excellence. Harris's extensive experience includes roles at prominent organizations where she spearheaded initiatives that significantly enhanced operational efficiency and service quality. Her strategic vision and commitment to innovation have been key factors in her success and have earned her recognition as a thought leader in the field. At NEOGENOMICS, Harris has been pivotal in expanding the company's capabilities and reach. Under her guidance, the enterprise operations team has achieved notable milestones, including the development of new testing platforms and the expansion of laboratory services. Harris's dedication to advancing cancer research and her ability to navigate the complexities of the healthcare landscape have solidified NEOGENOMICS' position as a leader in precision medicine. Her contributions continue to drive the company's growth and its impact on improving patient care.